Combination of cisplatin/S-1 in the treatment of patients with advanced gastric or gastroesophageal adenocarcinoma: Results of noninferiority and safety analyses compared with cisplatin/5-fluorouracil in the First-Line Advanced Gastric Cancer Study-Reference-Cited by-同舟云学术

Combination of cisplatin/S-1 in the treatment of patients with advanced gastric or gastroesophageal adenocarcinoma: Results of noninferiority and safety analyses compared with cisplatin/5-fluorouracil in the First-Line Advanced Gastric Cancer Study

Published:2013-11 Issue:17 Volume:49 Page:3616-3624
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Ajani J.A.,Buyse M.,Lichinitser M.,Gorbunova V.,Bodoky G.,Douillard J.Y.,Cascinu S.,Heinemann V.,Zaucha R.,Carrato A.,Ferry D.,Moiseyenko V.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference23 articles.

1. The role of chemotherapy in metastatic gastric cancer;Pasini;Anticancer Res,2011

2. Gastric cancer: a primer on the epidemiology and biology of the disease and an overview of the medical management of advanced disease;Shah;J Natl Compr Canc Netw,2010

3. Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data;Wagner;J Clin Oncol,2006

4. Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC)-gastrointestinal cancer group;Van Cutsem;Eur J Cancer,2008

5. Clinical studies of three oral prodrugs of 5-fluorouracil (capecitabine, UFT, S-1): a review;Malet-Martino;Oncologist,2002

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Estimating survival scenarios in advanced or metastatic gastric and oesophageal adenocarcinoma: a systematic review of randomized-controlled trials;Current Medical Research and Opinion;2024-07-13

2. Comparative analysis of thoracoscopic and open extrapleural surgery in the treatment of neonatal type III esophageal atresia;2023-12-28

3. S-1 and 5-Fluorouracil-related adverse events in patients with advanced gastric cancer: A meta-analysis;PLOS ONE;2023-08-11

4. S-1 maintenance therapy in Caucasian patients with metastatic esophagogastric adenocarcinoma–final results of the randomized AIO MATEO phase II trial;ESMO Open;2023-06

5. Docetaxel plus S-1 versus docetaxel plus capecitabine as first-line treatment for advanced breast cancer patients: a prospective randomized phase II study;Journal of the National Cancer Center;2023-06